1. Home
  2. TXMD vs INBS Comparison

TXMD vs INBS Comparison

Compare TXMD & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • INBS
  • Stock Information
  • Founded
  • TXMD 2008
  • INBS 2016
  • Country
  • TXMD United States
  • INBS United States
  • Employees
  • TXMD N/A
  • INBS N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • INBS Medical Specialities
  • Sector
  • TXMD Health Care
  • INBS Health Care
  • Exchange
  • TXMD Nasdaq
  • INBS Nasdaq
  • Market Cap
  • TXMD 12.3M
  • INBS 11.7M
  • IPO Year
  • TXMD N/A
  • INBS N/A
  • Fundamental
  • Price
  • TXMD N/A
  • INBS $1.15
  • Analyst Decision
  • TXMD
  • INBS
  • Analyst Count
  • TXMD 0
  • INBS 0
  • Target Price
  • TXMD N/A
  • INBS N/A
  • AVG Volume (30 Days)
  • TXMD 16.0K
  • INBS 294.6K
  • Earning Date
  • TXMD 11-11-2025
  • INBS 11-06-2025
  • Dividend Yield
  • TXMD N/A
  • INBS N/A
  • EPS Growth
  • TXMD N/A
  • INBS N/A
  • EPS
  • TXMD N/A
  • INBS N/A
  • Revenue
  • TXMD $2,559,000.00
  • INBS $3,052,532.00
  • Revenue This Year
  • TXMD $427.09
  • INBS $778.48
  • Revenue Next Year
  • TXMD N/A
  • INBS N/A
  • P/E Ratio
  • TXMD N/A
  • INBS N/A
  • Revenue Growth
  • TXMD 156.93
  • INBS N/A
  • 52 Week Low
  • TXMD $0.70
  • INBS $1.01
  • 52 Week High
  • TXMD $2.44
  • INBS $2.75
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 44.55
  • INBS 39.44
  • Support Level
  • TXMD $0.99
  • INBS $1.09
  • Resistance Level
  • TXMD $1.11
  • INBS $1.17
  • Average True Range (ATR)
  • TXMD 0.03
  • INBS 0.08
  • MACD
  • TXMD 0.00
  • INBS -0.01
  • Stochastic Oscillator
  • TXMD 57.85
  • INBS 30.70

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: